17:03 EDT Humacyte (HUMA) files $350M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUMA:
- Humacyte initiated with an Overweight at Barclays
- Humacyte’s Earnings Call: Progress Amid Challenges
- Humacyte price target lowered to $3.50 from $5 at TD Cowen
- Humacyte’s Strategic Positioning and Growth Potential Justifies Buy Rating Despite Revenue Shortfall
- Humacyte price target lowered to $3 from $4 at H.C. Wainwright